Extended donor criteria in lung transplantation: Impact on organ allocation

Journal of Thoracic and Cardiovascular Surgery

Volumn 131, Issue 5, 2006, Pages 1154-1160

  Botha, Phil ^a   Trivedi, Dipesh ^a   Weir, Christopher J ^b   Searl, Cait P ^a   Corris, Paul A ^c   Dark, John H ^a   Schueler, Stephan V B ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIBODY SPECIFICITY; ARTICLE; BRONCHIOLITIS OBLITERANS; BRONCHOSCOPY; DISEASE FREE SURVIVAL; FEMALE; GRAFT DYSFUNCTION; HUMAN; LUNG TRANSPLANTATION; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL;

ADULT; BRONCHIOLITIS OBLITERANS; DONOR SELECTION; FEMALE; GRAFT SURVIVAL; HEALTH CARE RATIONING; HEART TRANSPLANTATION; HUMANS; LUNG DISEASES; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 33646190294     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2005.12.037     Document Type: Article

References (19)

1. UK Transplant in the United Kingdom 2003-2004 (2004), UK Transplant, Bristol, UK ISSN 1741-6949
2. Thabut G., Mal H., Castier Y., Groussard O., Brugiere O., Marrash-Chahla R., et al. Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis. J Thorac Cardiovasc Surg 126 (2003) 469-475
3. Hosenpud J.D., Bennett L.E., Keck B.M., Edwards E.B., and Novick R.J. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease. Lancet 351 (1998) 24-27
4. Gabbay E., Williams T.J., Griffiths A.P., MacFarlane L.M., Kotsimbos T.C., Esmore D.S., et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 160 (1999) 265-271
5. Pierre A.F., Sekine Y., Hutcheon M.A., Waddell T.K., and Kheshavjee S.H. Marginal donor lungs. a reassessment. J Thorac Cardiovasc Surg 123 (2002) 421-428
6. Lardinois D., Banysch M., Korom S., Hillinger S., Rousson V., Boehler A., et al. Extended donor lungs. eleven years experience in a consecutive series. Eur J Cardiothorac Surg 27 (2005) 762-767
7. Christie J.D., Carby M., Bag R., Corris P., Hertz M., and Weill D. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction. Part II: Definition-consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 24 (2005) 1454-1459
8. Estenne M.M., Boehler A., Egan J.J., Frost A., Hertz M., Mallory G.B., et al. Bronchiolitis obliterans syndrome 2001. an update of the diagnostic criteria. J Heart Lung Transplant 21 (2002) 297-310
9. Kron I., Tribble C., Kern J., Daniel T., Rose C., Truwit J., et al. Successful transplantation of marginally acceptable thoracic organs. Ann Surg 217 (1993) 518-524
10. Straznicka M., Follette D.M., Eisner M.D., Roberts P.F., Menza R.L., and Babcock W.D. Aggressive management of lung donors classified as unacceptable. excellent recipient survival one year after transplantation. J Thorac Cardiovasc Surg 124 (2002) 250-258
11. Sundaresan S., Semenkovich J., Ochoa L., Richardson G., Trulock E., Cooper J., et al. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg 109 (1995) 1075-1080
12. Bhorade S.M., Vigneswaran W., McCabe M.A., and Garrity E.A. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant 19 (2000) 1200-1204
13. Puskas J.D., Winton T.L., Miller J.D., Scavuzzo M., and Patterson G.A. Unilateral donor lung dysfunction does not preclude successful contralateral single lung transplantation. J Thorac Cardiovasc Surg 103 (1992) 1015-1018
14. Szeto W.Y., Kreisel D., Karakousis G.C., Pochettino A., Sterman D.H., Kotloff R.M., et al. Cardiopulmonary bypass for bilateral sequential lung transplantation in patients with chronic obstructive pulmonary disease without adverse effect on lung function and clinical outcome. J Thorac Cardiovasc Surg 124 (2002) 241-249
15. Charman S.C., Sharples L.D., McNeil K.D., and Wallwork J. Assessment of survival benefit after lung transplantation by patient diagnosis. J Heart Lung Transplant 21 (2002) 226-232
16. Sundaresan R.S., Shiraishi Y., Trulock E.P., Manley J., Lynch J., Cooper J.D., et al. Single or bilateral lung transplant for emphysema?. J Thorac Cardiovasc Surg 112 (1996) 1485-1495
17. De Meester J., Smits J.M., Persijn G.G., and Haverich A. Listing for lung transplantation. life expectancy and transplant effect, stratified by type of end-stage lung disease, the Eurotransplant experience. J Heart Lung Transplant 20 (2001) 518-524
18. Meyers B.F., Lynch J.P., Trulock E.P., Guthrie T., Cooper J.D., and Patterson G.A. Single versus bilateral lung transplantation for idiopathic pulmonary fibrosis. a ten-year institutional experience. J Thorac Cardiovasc Surg 120 (2000) 99-107
19. Fisher A.J., Wardle J., Dark J.H., and Corris P.A. Non-immune acute graft injury after lung transplantation and the risk of subsequent bronchiolitis obliterans syndrome (BOS). J Heart Lung Transplant 21 (2002) 1206-1212